Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurriën M Ten Berg

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 19, 2020
Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructive cardiomyopathyFatih Arslan, Fatima Akdim, Jurriën M Ten Berg
Journal of Cardiovascular Translational Research|April 2, 2013
Platelet function testing and tailored antiplatelet therapyPaul W A Janssen, Jurriën M ten Berg
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Antiplatelet and anticoagulant therapy in elective percutaneous coronary interventionJurriën M ten Berg, HW Thijs Plokker, Freek WA Verheugt
Blood Reviews|April 22, 2014
The use of platelet function testing in PCI and CABG patientsPaul W A Janssen, Jurriën M ten Berg, Christian M Hackeng
Journal of Interventional Cardiology|August 25, 2017
High risk of stent thrombosis in the first 6 months after coronary stenting: Do not discontinue clopidogrel early after ACSBastiaan Zwart, Thea C Godschalk, Johannes C Kelder, et al.
International Journal of Cardiovascular Interventions|May 31, 2002
Provisional stenting in the real world: results in 1058 consecutive patients undergoing percutaneous coronary angioplastyJurriën M Ten Berg, Johannes C Kelder, Maarten Jan Suttorp, et al.
World Journal of Cardiology|March 27, 2015
Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-upRoel Jr Snijder, Maarten J Suttorp, Jurriën M Ten Berg, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 14, 2023
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE TrialsWout W A van den Broek, Nabil Mani, Jaouad Azzahhafi, et al.
Current Treatment Options in Cardiovascular Medicine|September 16, 2010
Coronary stent thrombosis in the current era: challenges and opportunities for treatmentBastiaan Zwart, Jochem W van Werkum, Antonius A C M Heestermans, et al.
Journal of Cardiology Cases|December 12, 2018
Transcatheter mitral paravalvular leakage closure: A beautiful last resortMartin J Swaans, Vincent Michiels, Vincent J Nijenhuis, et al.
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 19, 2020
Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructive cardiomyopathyFatih Arslan, Fatima Akdim, Jurriën M Ten Berg
Journal of Cardiovascular Translational Research|April 2, 2013
Platelet function testing and tailored antiplatelet therapyPaul W A Janssen, Jurriën M ten Berg
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Antiplatelet and anticoagulant therapy in elective percutaneous coronary interventionJurriën M ten Berg, HW Thijs Plokker, Freek WA Verheugt
Blood Reviews|April 22, 2014
The use of platelet function testing in PCI and CABG patientsPaul W A Janssen, Jurriën M ten Berg, Christian M Hackeng
Journal of Interventional Cardiology|August 25, 2017
High risk of stent thrombosis in the first 6 months after coronary stenting: Do not discontinue clopidogrel early after ACSBastiaan Zwart, Thea C Godschalk, Johannes C Kelder, et al.
International Journal of Cardiovascular Interventions|May 31, 2002
Provisional stenting in the real world: results in 1058 consecutive patients undergoing percutaneous coronary angioplastyJurriën M Ten Berg, Johannes C Kelder, Maarten Jan Suttorp, et al.
World Journal of Cardiology|March 27, 2015
Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-upRoel Jr Snijder, Maarten J Suttorp, Jurriën M Ten Berg, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 14, 2023
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE TrialsWout W A van den Broek, Nabil Mani, Jaouad Azzahhafi, et al.
Current Treatment Options in Cardiovascular Medicine|September 16, 2010
Coronary stent thrombosis in the current era: challenges and opportunities for treatmentBastiaan Zwart, Jochem W van Werkum, Antonius A C M Heestermans, et al.
Journal of Cardiology Cases|December 12, 2018
Transcatheter mitral paravalvular leakage closure: A beautiful last resortMartin J Swaans, Vincent Michiels, Vincent J Nijenhuis, et al.
Pageof 21